Geistlich Pharma Ag
Clinical trials sponsored by Geistlich Pharma Ag, explained in plain language.
-
New bone graft material tested for back surgery fusion
Disease control OngoingThis study is observing how well a bone graft material called Orthoss® works when mixed with a patient's own bone during spinal fusion surgery. It involves 65 adults with specific lower back conditions who need surgery to stabilize their spine. Researchers are checking if the spi…
Sponsor: Geistlich Pharma AG • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
New hope for tough pancreatic cancer cases in early drug trial
Disease control OngoingThis is a first-in-human study to find a safe dose of a new drug, GP-2250, when given with the chemotherapy gemcitabine. It is for adults with advanced pancreatic cancer that has continued to grow despite prior treatment. The main goal is to check for side effects and see how the…
Phase: PHASE1 • Sponsor: Geistlich Pharma AG • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC